Thoroughbred Financial Services »

Halozyme Therapeutics shares owned by Thoroughbred Financial Services

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Thoroughbred Financial Services from 13F filings

Historical chart of Thoroughbred Financial Services investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Thoroughbred Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Thoroughbred Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 21k 73.32
2025-06-30 $1.1M 21k 51.99